Literature DB >> 11233235

Cost-effectiveness associated with the diagnosis and staging of non-small-cell lung cancer.

H Osada1, K Kojima, H Tsukada, Y Nakajima, K Imamura, J Matsumoto.   

Abstract

OBJECTIVE: We evaluated how much time and money could be saved without compromising overall results in treating lung cancer. SUBJECTS AND METHODS: We retrospectively evaluated 318 patients for T- and M-factors and 335 for N-factor. If bronchoscopy failed to diagnose a mass lesion believed to be malignant in x-ray computed tomography (CT), we proceeded to direct thoracotomy without needle or video-assisted biopsy. When mediastinal nodes were negative in CT, we proceeded to direct thoracotomy without mediastinoscopy. We searched routinely for distant metastasis with brain and abdominal CTs and bone scans.
RESULTS: Lesions suspected of malignancy in CT were pathologically malignant in 93%. A total of 82.8% of patients with CT-negative mediastinum were without metastasis. The remainder, with metastasis, had a postoperative 5-year survival of 23.5%. Brain CT scans were positive in only 2.2%, abdominal CT scans in 2.4%, and bone scans in 5.0%, for patients with a cT1/T2 non-cN2 lesion.
CONCLUSION: Brain and abdominal CT scans and bone scans may be omitted for cT1/T2 and non-cN2 lesions in CT. CT-negative mediastinum then leads to direct thoracotomy. The vast majority of patients may thus undergo surgery earlier with less physical and financial burden. The cost saving was calculated to be 59.4% per cT1/T2 non-cN2 patient, or US$666,815, for population evaluated based on cost-effectiveness.

Entities:  

Mesh:

Year:  2001        PMID: 11233235     DOI: 10.1007/bf02913116

Source DB:  PubMed          Journal:  Jpn J Thorac Cardiovasc Surg        ISSN: 1344-4964


  13 in total

Review 1.  Pretreatment minimal staging and prognostic factors for non-small cell lung cancer.

Authors:  R Feld; R Abratt; S Graziano; J Jassem; L Lacquet; V Ninane; M Paesmans; P Rocmans; C Schiepers; R Stahel; R Stephens
Journal:  Lung Cancer       Date:  1997-06       Impact factor: 5.705

2.  The cost of diagnosis: a comparison of four different strategies in the workup of solitary radiographic lung lesions.

Authors:  B Goldberg-Kahn; J C Healy; J W Bishop
Journal:  Chest       Date:  1997-04       Impact factor: 9.410

3.  Role of computed tomography and mediastinoscopy in preoperative staging of lung carcinoma.

Authors:  J P Brion; L Depauw; G Kuhn; P de Fracquen; J Friberg; J Struyven
Journal:  J Comput Assist Tomogr       Date:  1985 May-Jun       Impact factor: 1.826

Review 4.  Pretreatment minimal staging for non-small cell lung cancer: an updated consensus report.

Authors:  P Goldstraw; P Rocmans; D Ball; N Barthelemy; J Bonner; M Carette; N Choi; B Emami; D Grunenwald; M Hazuka
Journal:  Lung Cancer       Date:  1994-11       Impact factor: 5.705

5.  Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung.

Authors:  F G Pearson; N C DeLarue; R Ilves; T R Todd; J D Cooper
Journal:  J Thorac Cardiovasc Surg       Date:  1982-01       Impact factor: 5.209

6.  Clinical prognostic factors in surgically treated stage IIIA-N2 non-small cell lung cancer: analysis of the literature.

Authors:  J F Vansteenkiste; P R De Leyn; G J Deneffe; T E Lerut; M G Demedts
Journal:  Lung Cancer       Date:  1998-01       Impact factor: 5.705

7.  Efficacy and benefit of mediastinal computed tomography as a selection method for mediastinoscopy.

Authors:  M Thermann; R Bluemm; U Schroeder; E Wassmuth; R Dohmann
Journal:  Ann Thorac Surg       Date:  1989-10       Impact factor: 4.330

8.  Surgical management of non-small-cell lung cancer with ipsilateral mediastinal node metastasis (N2 disease).

Authors:  P Goldstraw; G C Mannam; D K Kaplan; P Michail
Journal:  J Thorac Cardiovasc Surg       Date:  1994-01       Impact factor: 5.209

9.  Computed tomography of mediastinal lymph nodes in nonsmall cell lung cancer. A new approach based on the lymphatic pathway of tumor spread.

Authors:  J N Buy; M A Ghossain; F Poirson; M Bazot; E Meary; L Malbec; J Rochemaure; B Lebeau; J Prudent; F Capron
Journal:  J Comput Assist Tomogr       Date:  1988 Jul-Aug       Impact factor: 1.826

10.  Computed tomography for evaluation of mediastinal lymph nodes in lung cancer: correlation with surgical staging.

Authors:  R H Breyer; N Karstaedt; S A Mills; F R Johnston; R H Choplin; N T Wolfman; A S Hudspeth; A R Cordell
Journal:  Ann Thorac Surg       Date:  1984-09       Impact factor: 4.330

View more
  3 in total

1.  Prognostic significance of persistent mediastinal metastasis following induction therapy in large (> or = 2 cm) N2 or N3 non-small cell lung cancer.

Authors:  Noriyoshi Sawabata; Mitsunori Ohta; Hajime Maeda; Shin-ichi Takeda; Hiroshi Hirano; Yoshitomo Okumura; Hiroki Asada
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2003-04

2.  Impact of neuroimaging in the pretreatment evaluation of early stage non-small cell lung cancer.

Authors:  Garrett T Wasp; Christopher Del Prete; Jonathan A D Farrell; Konstantin H Dragnev; Gregory Russo; Graham T Atkins; Joseph D Phillips; Gabriel A Brooks
Journal:  Heliyon       Date:  2020-06-29

Review 3.  Mediastinal lymph node staging for lung cancer.

Authors:  Noriyoshi Sawabata
Journal:  Mediastinum       Date:  2019-08-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.